دورية أكاديمية
أعرض في EDS

Treatment Options in Mal de Débarquement Syndrome: A Scoping Review.

التفاصيل البيبلوغرافية
العنوان: Treatment Options in Mal de Débarquement Syndrome: A Scoping Review.
المؤلفون: Kinkhabwala CM; Department of Otolaryngology-Head and Neck Surgery., Yuen E; Department of Otolaryngology-Head and Neck Surgery., Brennan E; MUSC Libraries., Cadena A; Department of Neurology, Charleston, Medical University of South Carolina, Charleston, South Carolina., Rizk HG; Department of Otolaryngology-Head and Neck Surgery.
المصدر: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2023 Apr 01; Vol. 44 (4), pp. e197-e203. Date of Electronic Publication: 2023 Feb 15.
نوع المنشور: Systematic Review; Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100961504 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4505 (Electronic) Linking ISSN: 15317129 NLM ISO Abbreviation: Otol Neurotol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins, c2001-
مواضيع طبية MeSH: Travel-Related Illness*, Humans ; Neurotransmitter Agents/therapeutic use ; Rehabilitation ; Physical Therapy Modalities
مستخلص: Objective: The purpose of this study was to review current treatment options available for mal de debarquement syndrome (MdDS).
Data Sources: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Review guidelines, we performed systematic search queries for MdDS-related texts. Documents must have been in the English language, and the time frame was all documents up until May 23, 2022.
Methods: Studies were selected if they were published in a peer-reviewed journal and if one of the primary objectives was the assessment of treatment for MdDS. The quality and validity of all documents were assessed by two independent co-investigators. Conflicts were resolved by a third investigator.
Results: One hundred ninety-four unique references were identified and underwent review. Ninety-seven were selected for full-text review, and 32 studies were ultimately included. Data were stratified by treatment methodology for MdDS. The categories used were pharmacologic, physical therapy, and neuromodulating stimulation.
Conclusions: Improvement in patient-reported outcomes is reported with several treatment modalities including specific protocols of vestibular rehabilitation, neuromodulating stimulation, and pharmacologic management with several types of neurotropic drugs.
Competing Interests: Conflicts of interest and source and source of funding: The authors have no disclosures, and no funding was granted for this research.
(Copyright © 2023, Otology & Neurotology, Inc.)
التعليقات: Comment in: Otol Neurotol. 2023 Sep 1;44(8):839. (PMID: 37525381)
Comment in: Otol Neurotol. 2023 Sep 1;44(8):838-839. (PMID: 37525384)
References: Brown JJ, Baloh RW. Persistent mal de debarquement syndrome: a motion-induced subjective disorder of balance. Am J Otolaryngol 1987;8:219–22.
Hain TC, Hanna PA, Rheinberger MA. Mal de debarquement. Arch Otolaryngol Head Neck Surg 1999;125:615–20.
Van Ombergen A, Van Rompaey V, Maes LK, et al. Mal de debarquement syndrome: a systematic review. J Neurol 2016;263:843–54.
Hain TC, Cherchi M. Mal de débarquement syndrome. Handb Clin Neurol 2016;137:391–5.
Van Ombergen A, Wuyts FL, Cha Y-H. Letter to the editor: Comment and erratum to “Mal de debarquement syndrome: a systematic review”. J Neurol 2016;263:855–60.
Varga Z, Horváth B, Liktor B, et al. Mal de débarquement syndrome—“Sickness of disembarkment”. Orv Hetil 2020;161:846–51.
Beh SC, Chiang HS, Sanderson C. The interconnections of Mal de Débarquement syndrome and vestibular migraine. Laryngoscope 2021;131:E1653–e1661.
Cha YH. Mal de debarquement syndrome: New insights. Ann N Y Acad Sci 2015;1343:63–8.
Cha YH, Baloh RW, Cho C, et al. Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. J Vestib Res 2020;30:285–93.
Cha YH, Brodsky J, Ishiyama G, et al. Clinical features and associated syndromes of mal de debarquement. J Neurol 2008;255:1038–44.
Cha YH. Less common neuro-otologic disorders. Continuum (Minneap Minn) 2012;18(5 Neuro-otology):1142–57.
Canceri JM, Brown R, Watson SR, et al. Examination of current treatments and symptom management strategies used by patients with mal de debarquement syndrome. Front Neurol 2018;9:943.
Cha YH, Chakrapani S, Craig A, et al. Metabolic and functional connectivity changes in mal de debarquement syndrome. PLoS One 2012;7:e49560.
Cha YH, Cui YY, Baloh RW. Comprehensive clinical profile of mal de debarquement syndrome. Front Neurol 2018;9:261.
Cha YH. Mal de debarquement. Semin Neurol 2009;29:520–7.
Cha YH, Cui Y. Rocking dizziness and headache: A two-way street. Cephalalgia 2013;33:1160–9.
Ghavami Y, Haidar YM, Ziai KN, et al. Management of mal de debarquement syndrome as vestibular migraines. Laryngoscope 2017;127:1670–5.
Arroll MA, Attree EA, Cha YH, et al. The relationship between symptom severity, stigma, illness intrusiveness and depression in mal de debarquement syndrome. J Health Psychol 2016;21:1339–50.
Macke A, LePorte A, Clark BC. Social, societal, and economic burden of mal de debarquement syndrome. J Neurol 2012;259:1326–30.
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018;169:467–73.
Health and Medical Sciences at the University of Adelaide SA. Joanna Briggs Institute (JBI) critical appraisal tools assist in assessing the trustworthiness, relevance and results of published papers. 2021. Available at: https://jbi.global/critical-appraisal-tools . Accessed December 7, 2022.
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis . JBI; 2020.
Moola S, Munn Z, Tufanaru C, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis . JBI; 2020.
Ampomah KK, Clark BC, Arnold WD, et al. An uncommon cause of headache and dizziness after cruise travel: Case report of mal de debarquement syndrome. J Osteopath Med 2021;121:471–4.
Nwagwu V, Patel R, Okudo J. Mal de debarquement syndrome: A rare entity-a case report and review of the literature. Case Rep Otolaryngol 2015;2015:918475.
Hoppes CW, Vernon M, Morrell RL, et al. Treatment of mal de debarquement syndrome in a computer-assisted rehabilitation environment. Mil Med 2021;187:e1011–5.
Yakushin SB, Zink R, Clark BC, et al. Readaptation treatment of mal de debarquement syndrome with a virtual reality app: A pilot study. Front Neurol 2020;11:814.
Schenk SM, Wagner JM, Miller JA, et al. Treatment of mal de debarquement syndrome in a deployed environment. Mil Med 2018;183(11–12):e775–8.
Dai M, Cohen B, Smouha E, et al. Readaptation of the vestibulo-ocular reflex relieves the mal de debarquement syndrome. Front Neurol 2014;5:124.
Dai M, Cohen B, Cho C, et al. Treatment of the mal de debarquement syndrome: A 1-year follow-up. Front Neurol 2017;8:175.
Mucci V, Perkisas T, Jillings SD, et al. Sham-controlled study of optokinetic stimuli as treatment for mal de debarquement syndrome. Front Neurol 2018;9:887.
Liphart J. Use of sensory reweighting for a woman with persistent mal de debarquement: A case report. J Geriatr Phys Ther 2015;38:96–103.
Page P. Sensorimotor training: A@ global approach for balance training. J Bodyw Mov Ther 2006;10:77–84.
Cha YH, Cui Y, Baloh RW. Repetitive transcranial magnetic stimulation for mal de debarquement syndrome. Otol Neurotol 2013;34:175–9.
Ding L, Shou G, Yuan H, et al. Lasting modulation effects of rTMS on neural activity and connectivity as revealed by resting-state EEG. IEEE Trans Biomed Eng 2014;61:2070–80.
Shou G, Yuan H, Urbano D, et al. Optimizing rTMS treatment of a balance disorder with EEG neural synchrony and functional connectivity. Annu Int Conf IEEE Eng Med Biol Soc 2016;2016:53–6.
Yuan H, Shou G, Gleghorn D, et al. Resting state functional connectivity signature of treatment effects of repetitive transcranial magnetic stimulation in mal de debarquement syndrome. Brain Connect 2017;7:617–26.
Cha YH, Deblieck C, Wu AD. Double-blind sham-controlled crossover trial of repetitive transcranial magnetic stimulation for mal de debarquement syndrome. Otol Neurotol 2016;37:805–12.
Cha YH, Urbano D, Pariseau N. Randomized single blind sham controlled trial of adjunctive home-based tDCS after rTMS for mal de debarquement syndrome: Safety, efficacy, and participant satisfaction assessment. Brain Stimul 2016;9:537–44.
Pearce AJ, Davies CP, Major BP. Efficacy of neurostimulation to treat symptoms of mal de debarquement syndrome. A preliminary study using repetitive transcranial magnetic stimulation. J Neuropsychol 2015;9:336–41.
Buard I, Lopez-Esquibel N, Schoeneberger S, et al. Transcranial magnetic stimulation as treatment for mal de debarquement syndrome: Case report and literature review. Cogn Behav Neurol 2020;33:145–53.
Chen Y, Cha YH, Li C, et al. Multimodal imaging of repetitive transcranial magnetic stimulation effect on brain network: A combined electroencephalogram and functional magnetic resonance imaging study. Brain Connect 2019;9:311–21.
Chen Y, Li C, Shou G, et al. Assessing rTMS effects in MdDS: Cross-modal comparison between resting state EEG and fMRI connectivity. Annu Int Conf IEEE Eng Med Biol Soc 2017;2017:1950–3.
Shou G, Yuan H, Urbano D, et al. Changes of symptom and EEG in mal de debarquement syndrome patients after repetitive transcranial magnetic stimulation over bilateral prefrontal cortex: A pilot study. Annu Int Conf IEEE Eng Med Biol Soc 2014;2014:4294–7.
Cha YH, Shou G, Gleghorn D, et al. Electrophysiological signatures of intrinsic functional connectivity related to rTMS treatment for mal de debarquement syndrome. Brain Topogr 2018;31:1047–58.
Zhang J, Abiose O, Katsumi Y, et al. Intrinsic functional connectivity is organized as three interdependent gradients. Sci Rep 2019;9:15976.
Cha YH, Gleghorn D, Doudican B. Occipital and cerebellar theta burst stimulation for mal de debarquement syndrome. Otol Neurotol 2019;40:e928–37.
Antal A, Boros K, Poreisz C, et al. Comparatively weak after-effects of transcranial alternating current stimulation (tACS) on cortical excitability in humans. Brain Stimul 2008;1:97–105.
Antal A, Paulus W. Transcranial alternating current stimulation (tACS). Front Hum Neurosci 2013;7:317.
Cha YH, Gleghorn D, Doudican BC. Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de débarquement syndrome. PLoS One 2022;17:e0263558.
Cha YH, Riley J, Gleghorn D, et al. Remotely monitored home-based neuromodulation with transcranial alternating current stimulation (tACS) for mal de débarquement syndrome. Front Neurol 2021;12:755645.
Ahn S, Gleghorn D, Doudican B, et al. Transcranial alternating current stimulation reduces network hypersynchrony and persistent vertigo. Neuromodulation 2021;24:960–8.
Cummins F. Rhythm as entrainment: The case of synchronous speech. J Phonetics 2009;37:16–28.
Mucci V, Canceri JM, Brown R, et al. Mal de debarquement syndrome: A survey on subtypes, misdiagnoses, onset and associated psychological features. J Neurol 2018;265:486–99.
Anacker C, Zunszain PA, Cattaneo A, et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 2011;16:738–50.
Boldrini M, Underwood MD, Hen R, et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009;34:2376–89.
Dale E, Pehrson AL, Jeyarajah T, et al. Effects of serotonin in the hippocampus: How SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectr 2016;21:143–61.
Zohar J, Westenberg HGM. Anxiety disorders: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000;101(S403):39–49.
Dai M, Raphan T, Cohen B. Adaptation of the angular vestibulo-ocular reflex to head movements in rotating frames of reference. Exp Brain Res 2009;195:553–67.
Guedry FE Jr., Graybiel A. Compensatory nystagmus conditioned during adaptation to living in a rotating room. J Appl Physiol 1962;17:398–404.
Haran FJ, Keshner EA. Sensory reweighting as a method of balance training for labyrinthine loss. J Neurol Phys Ther 2008;32:186–91.
Peterka RJ. Sensorimotor integration in human postural control. J Neurophysiol 2002;88:1097–118.
Koenigs M, Huey ED, Calamia M, et al. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neurosci 2008;28:12341–8.
Chen Y, Cha YH, Gleghorn D, et al. Brain network effects by continuous theta burst stimulation in mal de débarquement syndrome: Simultaneous EEG and fMRI study. J Neural Eng 2021;18.
المشرفين على المادة: 0 (Neurotransmitter Agents)
SCR Disease Name: Mal de debarquement
تواريخ الأحداث: Date Created: 20230215 Date Completed: 20230329 Latest Revision: 20230821
رمز التحديث: 20240628
DOI: 10.1097/MAO.0000000000003832
PMID: 36791362
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-4505
DOI:10.1097/MAO.0000000000003832